Clinical Trial Update: A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial of BI201335 for chronic hepatitis C in treatment-naive and relapsed patients has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BI201335

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 3 | Status: WITHDRAWN